High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms

The emerging interest in circulating tumor DNA (ctDNA) analyses for clinical trials has necessitated the development of a high‐throughput method for fast, reproducible, and efficient isolation of ctDNA. Currently, the majority of ctDNA studies use the manual QIAamp (QA) platform to isolate DNA from...

Full description

Bibliographic Details
Main Authors: Lisanne F. vanDessel, Silvia R. Vitale, Jean C. A. Helmijr, Saskia M. Wilting, Michelle van derVlugt‐Daane, Esther Oomen‐de Hoop, Stefan Sleijfer, John W. M. Martens, Maurice P. H. M. Jansen, Martijn P. Lolkema
Format: Article
Language:English
Published: Wiley 2019-02-01
Series:Molecular Oncology
Subjects:
automation
cell‐free DNA
circulating tumor DNA
isolation
Online Access:https://doi.org/10.1002/1878-0261.12415

Internet

https://doi.org/10.1002/1878-0261.12415

Similar Items